Jeffrey Berger, MD
Enriched profileCharles Aden Poindexter Associate Professor of Medicine; Associate Professor of Surgery · NYU Grossman School of Medicine
Jeffrey Berger is Charles Aden Poindexter Associate Professor of Medicine; Associate Professor of Surgery at NYU Grossman School of Medicine. OpenAlex indexes 687 publications with 29,370 citations (h-index 84); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Data verified 17 Aug 2026
Overview
Updated 15 Oct 2026
Jeffrey Berger, MD, MS, is Charles Aden Poindexter Associate Professor of Medicine at NYU Grossman School of Medicine / NYU Langone Health. The public record shows 687 publications with 29,370 citations (h-index 84), centered on Antiplatelet Therapy and Cardiovascular Diseases, Peripheral Artery Disease Management, Venous Thromboembolism Diagnosis and Management. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 5 companies, 5 NIH-funded awards (2013–2026).
- Most recent indexed publication: 2026 · Circulation research
- Top research focus: Antiplatelet Therapy and Cardiovascular Diseases
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 39 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 278.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 15 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE
Sponsor: Matthew Neal MD
- CHOlesterol Lowering and Residual Risk in Type 2 Diabetes
Sponsor: NYU Langone Health
- Subclinical Cardiovascular Disease in Psoriatic Disease
Sponsor: NYU Langone Health
Industry payments
Updated 15 Oct 2026
5 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Bayer Healthcare LLCProgram year20252 payments
- Amgen Inc.Program year20251 payment
- Amgen Inc.Program year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
92.5%Statin41.9%Atorvastatin Calcium52%Rosuvastatin Calcium49%Part D≥23 patientsCholesterol absorption inhibitor14.9%Ezetimibe100%Part D<11 patients+ 4 more classes in this area
Blood & clotting
7.5%Factor Xa inhibitor7.5%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 15 Oct 2026
5 NIH research awards on record, funded 2013–2026 per NIH RePORTER. The latest:
- Proteomics, outcomes and precision treatment of patients with chronic limb threatening ischemia (CLTI).
New York University School of Medicine
FY2026$872,787R01HL183504 - Mechanisms of Platelet Activity in Vascular Disease
New York University School of Medicine
FY2025$1,016,973R35HL144993 - Mechanisms of Platelet Activity in Vascular Disease
New York University School of Medicine
FY2024$996,660R35HL144993
Congress activity
Updated 15 Oct 2026
3 congress contributions (2018–2024) across ASH per OpenAlex. The most recent:
- Tetraspanin CD37 Regulates Platelet Hyperreactivity and Thrombosis
ASH Annual Meeting
ASH2024Co-author - Identification of a Whole Blood Signature for Venous Thromboembolism
ASH Annual Meeting
ASH2018Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 15 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Validation of Brachial Vein Endothelial Transcriptomics to Assess the Coronary Vasculature.
Circulation research
Letter2026 - Whole blood epigenomic and transcriptomic characterization identifies vulnerable molecular subtypes of chronic coronary disease.
Nature communications
Article2026 - Bleeding history is associated with lower risk of cardiovascular events in a cohort undergoing lower extremity revascularization.
Journal of thrombosis and thrombolysis
Article2026 - Precision Antiplatelet Therapy: The Promise and Complexity of Pharmacogenomic Antiplatelet Therapy.
Circulation. Cardiovascular interventions
Editorial2026 - Whole-blood transcriptomics differentiates circulating gene expression between coronary artery disease and peripheral artery disease.
Vascular medicine (London, England)
Letter2026
Most-cited works
by citation count (OpenAlex)- 01Initial Invasive or Conservative Strategy for Stable Coronary DiseaseArticle2,407 citations2020
- 02Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19Article1,115 citations2020
- 03Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysisReview1,051 citations2009
- 04Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health SystemArticle850 citations2020
- 05Aspirin for the Primary Prevention of Cardiovascular Events in Women and MenArticle784 citations2006
Network
Updated 15 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 15 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/jeffrey-berger-md-9c3661c9
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Doximity
doximity.com/pub/jeffrey-berger-md-c396e43c
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Doximity
doximity.com/pub/jeffrey-berger-md-c818dafc
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
nyulangone.org/doctors/1912172701/jeffrey-s-berger
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗ - LinkedIn
linkedin.com/in/jeffrey-berger-0214295
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - X / Twitter
x.com/plateletdoc
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
Mentions by others
where others cite or feature them- Other
healio.com/news/cardiology/20210511/5-questions-with-jeffrey-s-berger-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗ - X / Twitter
X/Twitter handle @PlateletDoc (Dr. Jeffrey Berger)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 15 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Editorial & leadership roles
journal and society appointments- Editorial Board Member
Cardiology Today
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →research.weill.cornell.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com ↗
Secondary affiliations
appointments beyond the home institution- Director
Center for the Prevention of Cardiovascular Disease, NYU Langone Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.nyu.edu ↗ - Director
Cardiovascular Thrombosis Program, NYU Langone Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.nyu.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
- Principal Investigator
Berger Lab, NYU Grossman School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.nyu.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →themedicinementors.libsyn.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nyulangone.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Jill Buyon, MD
NYU Grossman School of Medicine
Mark Mulligan, MD
NYU Grossman School of Medicine
David Goldfarb, MD
NYU Grossman School of Medicine
Harmony Reynolds, MD
NYU Grossman School of Medicine
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)